scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Marc N. Potenza | Q25336883 |
P2093 | author name string | Justin D Wareham | |
P2860 | cites work | Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings | Q24641954 |
The neurobiology and genetics of impulse control disorders: relationships to drug addictions | Q24642641 | ||
Gambling urges in pathological gambling: a functional magnetic resonance imaging study | Q48229227 | ||
Randomized trial of brief motivational treatments for pathological gamblers: More is not necessarily better | Q48254147 | ||
Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making | Q48287968 | ||
Cognitive and behavioral treatment of pathological gambling: a controlled study | Q48737738 | ||
Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers | Q48897879 | ||
Pathological gambling is linked to reduced activation of the mesolimbic reward system | Q49157389 | ||
Impulse-control disorders in adolescent psychiatric inpatients: co-occurring disorders and sex differences. | Q51897954 | ||
Evaluation of the continuum of gambling problems using the DSM-IV. | Q51903787 | ||
Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. | Q51920129 | ||
Impulse control disorders in adult psychiatric inpatients. | Q51924515 | ||
Taking chances: problem gamblers and mental health disorders--results from the St. Louis Epidemiologic Catchment Area Study. | Q51992818 | ||
Effects of abstinence and smoking on information processing in adolescent smokers. | Q52139723 | ||
Pathological gambling and obsessive-compulsive disorder: towards a spectrum of disorders of volition. | Q52291507 | ||
Prospective prevalence of pathologic gambling and medication association in Parkinson disease | Q57083763 | ||
A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling | Q73794738 | ||
Gender differences in gambling progression | Q77159981 | ||
Cognitive treatment of pathological gambling | Q77393916 | ||
Impulsivity and compulsivity in pathological gambling and obsessive-compulsive disorder | Q80636846 | ||
Gamblers anonymous and cognitive-behavioral therapies for pathological gamblers | Q28241596 | ||
Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin Registry | Q30988864 | ||
Cognitive psychopathology of problem gambling | Q33723178 | ||
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling | Q33948583 | ||
A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling | Q34135868 | ||
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? | Q34380515 | ||
Should addictive disorders include non-substance-related conditions? | Q34560147 | ||
Association of dopamine agonist use with impulse control disorders in Parkinson disease | Q35567194 | ||
Pathological gambling: a comprehensive review of biobehavioral findings | Q35789699 | ||
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study | Q36341411 | ||
DSM-IV pathological gambling in the National Comorbidity Survey Replication | Q36540767 | ||
Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis | Q36882312 | ||
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling | Q36931279 | ||
Gender differences in the associations between past-year gambling problems and psychiatric disorders | Q36979137 | ||
Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease | Q37018645 | ||
Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. | Q37093043 | ||
Brief motivational interventions for college student problem gamblers | Q37378934 | ||
Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals | Q37412478 | ||
The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions | Q37472829 | ||
A systematic review and meta-analysis of cognitive-behavioural interventions to reduce problem gambling: hedging our bets? | Q37484593 | ||
Shared genetic contributions to pathological gambling and major depression in men. | Q40391328 | ||
A hierarchy of gambling disorders in the community | Q40545491 | ||
Frontal lobe dysfunction in pathological gambling patients | Q40646097 | ||
Sertraline treatment of pathological gambling: a pilot study | Q42646084 | ||
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling | Q44351769 | ||
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. | Q44441093 | ||
Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial | Q44484632 | ||
Gender-related differences in the characteristics of problem gamblers using a gambling helpline. | Q45955141 | ||
Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Q46487082 | ||
Pathological gambling: focusing on the addiction, not the activity | Q46921494 | ||
Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys | Q46921528 | ||
An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers | Q48156393 | ||
N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study | Q48196146 | ||
P433 | issue | 5 | |
P921 | main subject | problem gambling | Q748309 |
P304 | page(s) | 242-247 | |
P577 | publication date | 2010-09-01 | |
P1433 | published in | American Journal of Drug and Alcohol Abuse | Q15755465 |
P1476 | title | Pathological gambling and substance use disorders | |
P478 | volume | 36 |
Q44835101 | A double-blind, placebo-controlled trial of topiramate for pathological gambling |
Q36052927 | A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity |
Q39396119 | Assessing the psychometric properties of two food addiction scales |
Q60545966 | At-risk gambling in patients with severe mental illness: Prevalence and associated features |
Q45326591 | Binge-drinking and non-partner aggression are associated with gambling among Veterans with recent substance use in VA outpatient treatment |
Q37603928 | Biological contributions to addictions in adolescents and adults: prevention, treatment, and policy implications |
Q92445927 | Clinical Improvements in Comorbid Gambling/Cocaine Use Disorder (GD/CUD) Patients Undergoing Repetitive Transcranial Magnetic Stimulation (rTMS) |
Q42639191 | Co-occurrence of addictive behaviours: personality factors related to substance use, gambling and computer gaming |
Q35670338 | Compulsive features in behavioural addictions: the case of pathological gambling |
Q57790904 | Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior |
Q36286365 | Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling |
Q47210001 | Does size matter? An examination of problem gamblers' skin conductance responses to large and small magnitude rewards. |
Q37676452 | Endogenous cortisol levels are associated with an imbalanced striatal sensitivity to monetary versus non-monetary cues in pathological gamblers. |
Q35690154 | Gambling disorder and other behavioral addictions: recognition and treatment |
Q38626351 | Latent traits of impulsivity and compulsivity: toward dimensional psychiatry. |
Q57602440 | Manifesto for a European research network into Problematic Usage of the Internet |
Q33892948 | Obsessive-compulsive aspects and pathological gambling in an Italian sample |
Q33551968 | Pathological Gambling and Associated Drug and Alcohol Abuse, Emotion Regulation, and Anxious-Depressive Symptomatology |
Q37385834 | Pathological Gambling: Neuropsychopharmacology and Treatment |
Q36091969 | Pathological gambling, problem gambling and sleep complaints: an analysis of the National Comorbidity Survey: Replication (NCS-R). |
Q24630556 | Patterns of and motivations for concurrent use of video games and substances |
Q52609143 | Piloting the addition of contingency management to best practice counselling as an adjunct treatment for rural and remote disordered gamblers: study protocol. |
Q52316361 | Prevalence and characteristics of addictive behaviors in a community sample: A latent class analysis. |
Q36951134 | Relations among delay discounting, addictions, and money mismanagement: implications and future directions |
Q63684322 | Relationship between attention-deficit hyperactivity disorder symptoms and problem gambling: A mediation analysis of influential factors among 7,403 individuals from the UK |
Q36678407 | Serotonin 1B receptor imaging in pathological gambling |
Q24616099 | Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity |
Q38265371 | The Application of an Etiological Model of Personality Disorders to Problem Gambling. |
Q36784257 | The involvement of the striatum in decision making |
Q52307294 | Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. |
Search more.